1220.6000 -49.70 (-3.91%)
NSE Aug 01, 2025 15:31 PM
Volume: 2.5M
 

1220.60
-3.91%
Karvy
Dr. Reddys Lab's (DRL) revenue, increased by 13.6% YoY to Rs40.2 bn, ishigher than our estimates of Rs 38.9bn; primarily due to good growth inEurope and Emerging market business.
Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended